Â¥
15.07
May 10
New Key Statistics Module, Z-Score and F-Score
SZSE:300142 Key Ratios
Market Cap ¥ M | 24,222.74 |
Enterprise Value ¥ M | 20,914.94 |
P/E(ttm) | 92.45 |
PE Ratio without NRI | 34.10 |
Forward PE Ratio | -- |
Price/Book | 2.59 |
Price/Sales | 6.22 |
Price/Free Cash Flow | 5,023.33 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.02 |
Revenue (TTM) ¥ M | 3,880.00 |
EPS (TTM) ¥ | 0.16 |
Beneish M-Score | -2.77 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 4.10 |
y-y EBITDA Growth Rate % | -62.00 |
EV-to-EBIT | 46.11 |
EV-to-EBITDA | 46.11 |
PEG | 8.32 |
Shares Outstanding M | 1,607.35 |
Net Margin (%) | 6.74 |
Operating Margin % | 24.83 |
Pre-tax Margin (%) | 11.48 |
Quick Ratio | 2.48 |
Current Ratio | 2.85 |
ROA % (ttm) | 1.68 |
ROE % (ttm) | 2.78 |
ROIC % (ttm) | 8.14 |
Dividend Yield % | 0.07 |
Altman Z-Score | 4.72 |
SZSE:300142 Number of Guru Trades
SZSE:300142 Volume of Guru Trades
Gurus Latest Trades with SZSE:300142
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300142 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Walvax Biotechnology Co Ltd Insider Transactions
No Available Data